News
$Sonnet BioTherapeutic (SONN.US)$ Sonnet Biotherapeutics Announces Issuance of U.S. Patent Covering a Variant Il-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more3
福贵吉祥 知足常乐 : Wasted
Trytosaveabit OP : Sonnet Biotherapeutics Holdings Inc - Patent Term Effective Until June 2044
Be a voice no echo : again